The increases were broadly consistent with those documented for approved GLP-1 receptor agonists in their respective SmPCs
Tirzepatide (Eli Lillys Mounjaro/Zepbound) is a dual GLP-1/GIP receptor agonist with four years of Phase 3 data, three FDA approvals, and a published cardiovascular outcomes trial
[3],[4] In addition, the traditional role of metformin in the early management of T2D is not always appropriate if not tolerated or contraindicated (eg, eGFR 20-25 mL/min/1.73 m 2
Compared to covered workers in other plan types, those in HDHP/SOs are more likely to be in a plan that has no cost sharing for prescriptions once the plan deductible is met (11% vs
This dual action has positioned Melanotan II as a unique option for individuals seeking a deeper, more even tan and enhanced libido support
Ozempic, which contains semaglutide as its active ingredient, has been associated with serious gastrointestinal problems, including gastroparesis (delayed stomach emptying) and pancreatitis